A detailed history of Dark Forest Capital Management LP transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Dark Forest Capital Management LP holds 11,799 shares of VERV stock, worth $58,995. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,799
Holding current value
$58,995
% of portfolio
0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$10.81 - $17.96 $127,547 - $211,910
11,799 New
11,799 $156,000
Q3 2022

Nov 14, 2022

SELL
$15.63 - $41.49 $5,064 - $13,442
-324 Reduced 86.17%
52 $2,000
Q2 2022

Aug 15, 2022

SELL
$11.14 - $23.17 $34,144 - $71,016
-3,065 Reduced 89.07%
376 $6,000
Q1 2022

May 13, 2022

SELL
$20.92 - $39.36 $232,128 - $436,738
-11,096 Reduced 76.33%
3,441 $78,000
Q4 2021

Feb 11, 2022

BUY
$31.94 - $54.82 $464,311 - $796,918
14,537 New
14,537 $536,000

Others Institutions Holding VERV

About Verve Therapeutics, Inc.


  • Ticker VERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,942,300
  • Market Cap $300M
  • Description
  • Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...
More about VERV
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.